More specifically, and in our interest to examine how local communities appropriate development interventions to fit their social landscape, we examine pathways to community acceptability of conditions in a cash transfer trial in Manicaland, Zimbabwe.
LR designed the overarching cash transfer trial and participated in the design of this sub-study.
SG conceived and oversaw the development and conduct of the cash transfer trial including this sub-study.
The community-randomised cash transfer trial that we report on in this paper began in July 2009 across 30 communities in Manicaland.
An early gene transfer trial for ornithine transcarbamylase deficiency at the University of Pennsylvania, which resulted in the death of a young participant, is regarded as "the most famous conflict-of-interest case in medicine" [ 2].
To counterbalance for individual variations from one session to the next, which were considerable throughout the training, and for problems with artefacts at the beginning, the transfer trial data from double sessions 7 to 14 were entered into the analysis.
Following acquisition of the discrimination, rats were tested in a series of transfer trials, where the training shapes were transformed in a variety of ways.
Two training sessions of 45 minutes each were administered on the same day, usually as double sessions, according to the following protocol: Children started with a block of 40 feedback-trials, in randomized order for positivity and negativity, followed by a block of 30 EEG transfer trials and by a block of 40 transfer trials with training cards.
A few recent cash transfer trials in sub-Saharan Africa have found CCTs to outperform UCTs, particularly in relation to improving the school attendance and performance of marginalized children (Baird et al. 2011; Akresh et al. 2013).
"Given the progress in the field, I am confident that the existing regulatory authorities can effectively review most gene transfer protocols and that a streamlined process will reduce duplication and delays in getting gene transfer trials initiated," said NIH Director Francis Collins in a statement today.
